Evaluation of phytomedicinal potential of perillyl alcohol in an in vitro Parkinson's Disease model
Authors:
- 1 August 2018
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 79 (5) , 218-224
Abstract
Preclinical Research & Development Parkinson's disease (PD) is the second most common neurodegenerative disorder that affects approximately 10 million people worldwide. The risk of developing PD and similar neurodegenerative disorders increases with age and an estimated 4% people are diagnosed with the disease before reaching the age of 50. Oxidative stress, cytotoxicity, and mitochondrial dysfunction are common features exhibited in the development of PD. The 6‐hyroxydopamine (6‐OHDA) model of PD is one of the most well characterized and studied models of the disease. 6‐OHDA, a neurotoxin, can induce most characteristic features of the disease, including mitochondrial dysfunction in‐vivo and in‐vitro. SH‐SY5Y is a neuroblastoma cell line of human origin that has been used for dose response studies on PD in the past. Based on previous data, we have used SH‐SY5Y cells as an in‐vitro model of PD to analyse the phytomedicinal potential of perillyl alcohol (PA), a monoterpenoid obtained from essential oils of various plants such as sage, peppermint and lavender. We have found that pretreatment with PA (10 μM and 20 μM) mitigated 6‐OHDA (150 μM) induced cytotoxicity in a dose‐dependent manner. We observed marked restoration of cell viability and mitochondrial membrane potential (MMP) as well as reduced reactive oxygen species generation, Cytochrome c immunofluorescence and DNA fragmentation after treatment with PA. On the basis of on our data, we have come to the conclusion that PA demonstrates sufficient neuroprotective activity to provide new avenues in therapy of PD and its apparent target being restoration of MMP can lead to better understanding of the disease.Keywords
This publication has 24 references indexed in Scilit:
- Ginsenoside Rb1 Attenuates Oxygen-Glucose Deprivation-Induced Apoptosis in SH-SY5Y Cells via Protection of Mitochondria and Inhibition of AIF and Cytochrome c ReleaseMolecules, 2013
- Antioxidants in Huntington's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Protective Effect of Tetrahydroxystilbene Glucoside on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO PathwayPLOS ONE, 2011
- Mitochondrial dysfunction in Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Natural Antioxidants Protect Neurons in Alzheimer’s Disease and Parkinson’s DiseaseNeurochemical Research, 2009
- Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomasSurgical Neurology, 2008
- A Pilot Study of Perillyl Alcohol in Pancreatic CancerJournal of Surgical Research, 2008
- Parkinson's Disease Is Associated with Oxidative Damage to Cytoplasmic DNA and RNA in Substantia Nigra NeuronsThe American Journal of Pathology, 1999
- Reactive Oxygen Species and the Central Nervous SystemJournal of Neurochemistry, 1992
- A simple technique for quantitation of low levels of DNA damage in individual cellsExperimental Cell Research, 1988